Center for Diagnostic and Therapeutic Strategies in Pancreatic Cancer
Funded at North Dakota State University · NIH-11413546 · Data updated 2026-11-12
A dedicated program at North Dakota State University is building better tools and resources to speed up diagnoses and treatments for pancreatic cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | North Dakota State University NIH-funded |
| Lab location | 1 site (Fargo, United States) |
| Project start | March 1, 2016 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,778,045 |
| NIH project number | 5P20GM109024-10 |
| Project ID | NIH-11413546 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with pancreatic ductal adenocarcinoma or those at risk who could participate in future translational research projects, biomarker studies, or provide samples for studies.
✕Less likely to help
Patients not currently eligible for translational studies or whose condition is outside the scope of the research focus may not directly benefit.
What this research studies
This grant supports expanding core biomedical facilities and translational research to help people with pancreatic cancer. It focuses on creating and sharing data, Biostatistics support, animal models, and pilot projects to translate discoveries into patient care. The effort includes developing patient-derived mouse models and increasing collaboration among researchers to push new ideas toward clinical applications. The goal is to improve survival and outcomes for PDAC through better diagnostics and therapies.
Why it matters
Potential benefit: If successful, patients with pancreatic cancer could benefit from faster, more accurate diagnostics and new targeted therapies.
How similar studies have gone: Past similar centers have expanded research capacity and produced numerous grants and publications, with some translating into animal and biomarker-based discoveries.
Where this research is happening
-
North Dakota State University
Fargo, United States Active
Researchers
- Principal investigator: Hamann, Mark T — North Dakota State University
- Study coordinator: Hamann, Mark T
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.